Author:
Visser Gepke,Rake Jan Peter,Labrune Philippe,Leonard James V.,Moses Shimon,Ullrich Kurt,Wendel Udo,Smit G. Peter A.
Publisher
Springer Science and Business Media LLC
Subject
Pediatrics, Perinatology, and Child Health
Reference21 articles.
1. Calderwood S, Kilpatrick L, Douglas SD, Freedman M, Smith-Whitley K, Rolland M, Kurtzberg J (2001) Recombinant human granulocyte colony-stimulating factor therapy for patients with neutropenia and/or neutrophil dysfunction secondary to glycogen storage disease type 1b. Blood 97: 376–382
2. Donadieu J, Bader-Meunier B, Bertrand Y, Lachaux A, Labrune P, Gougerot MA, Odièvre M, Gibeaud P, Yver A, Tchernia G, and others (1993) Recombinant human G-CSF (Lenograstim) for infectious complications in glycogen storage disease type Ib. Report of 7 cases. Nouv Rev Fr Hematol 35: 529–534
3. Donadieu J, Barkaoui M, Bezard F, Bertrand Y, Pondarre C, Guibaud P (2001) Renal carcinoma in a patient with glycogen storage disease Ib receiving long-term granulocyte colony-stimulating factor therapy [letter]. J Pediatr Hematol Oncol 22: 188–189
4. Erramouspe J, Heyneman CA (2000) Treatment and prevention of otitis media. Ann Pharmacother 34: 1452–1468
5. Frampton JE, Lee CR, Faulds D (1994) Filgrastim: a review of its pharmacological properties and therapeutic efficacy in neutropenia. Drugs 48: 731–760
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献